CKD is associated with dyslipidemia which comprises of normal to increased low-density lipoprotein cholesterol (LDL-C) concentrations, low high-density lipoprotein cholesterol (HDL-C) levels, and elevated levels of triglycerides (TGs), and apolipoprotein B (Apo B) containing lipoproteins [58]. This evidence concerns the gene APOB and metabolic syndrome.